Physician profile
John Booth
NPI 1528064292
$7,887.30
in general payments reported to CMS, 2019-2025
44 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.78 · 2020: $627 · 2021: $1,378 · 2022: $1,732 · 2023: $1,482 · 2024: $1,444 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,116.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,205.62 | 2020-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $1,066.52 | 2021-2025 | |
| Antares Pharma, INC. | $571.03 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $477.93 | 2023-2025 | Gemtesa, Orgovyx |
| Blue Earth Diagnostics | $467.32 | 2020-2025 | Posluma |
| Endo USA, INC. | $464.79 | 2024-2025 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $433.25 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $390.02 | 2020-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $249.54 | 2020-2023 | Jelmyto |
| Janssen Biotech, INC. | $218.99 | 2022-2025 | Erleada, Akeega |
| Amgen INC. | $217.76 | 2020-2022 | |
| Ambu INC. | $199.02 | 2022-2024 | |
| Progenics Pharmaceuticals, INC. | $191.43 | 2021-2025 | Pylarify |
| Accord Healthcare, INC. | $132.66 | 2023-2024 | |
| Bioprotect Medical, INC. | $128.87 | 2024-2025 | Bioprotect Balloon Implant System |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $126.41 | 2021 | |
| Travere Therapeutics, INC. | $119.39 | 2019-2022 | |
| Astellas Pharma US INC | $111.54 | 2021-2024 | Xtandi |
| Urovant Sciences INC | $110.57 | 2021-2022 | |
| Rochester Medical Corporation | $107.62 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $104.60 | 2020-2025 | Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $101.48 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $76.20 | 2022-2024 | Botox |
| Astrazeneca Pharmaceuticals Lp | $74.61 | 2020-2021 | |
| Cardinal Health 414 LLC | $49.08 | 2022-2025 | |
| Neotract INC. | $43.75 | 2020 | |
| Axonics, INC. | $43.08 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $42.19 | 2024-2025 | Venxxiva, Tiopronin |
| Myovant Sciences INC. | $37.46 | 2021-2022 | |
| Teleflex LLC | $35.64 | 2024-2025 | Barrigel, Urolift |
| Pfizer INC. | $35.09 | 2021 | |
| Photocure INC | $28.34 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $28.06 | 2023 | Yonsa |
| Tolmar Pharmaceuticals, INC. | $27.76 | 2021 | |
| Tempus Ai, INC | $25.66 | 2024 | Xt Cdx |
| Tolmar, INC. | $24.05 | 2023 | |
| Mission Pharmacal Company | $20.08 | 2020 | |
| Boston Scientific Corporation | $18.02 | 2022 | |
| Halozyme INC | $16.83 | 2023 | |
| Alexion Pharmaceuticals, INC. | $15.70 | 2023 | Soliris |
| Genzyme Corporation | $15.64 | 2022 | |
| Immunitybio, INC. | $14.05 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $13.90 | 2023 | Bard Urinary Drainage Bag |
| Civco Medical Instruments | $5.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.